Wanbangde Pharmaceutical Holding Group: Notice on subsidiary products receiving US FDA drug certification for rare pediatric diseases

SZSI · May 8

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.